View Profile

Rassoul Dinarvand

Faculty of Pharmacy · Tehran University of Medical Sciences

https://researchid.co/dinarvand
@tums.ac.ir
491Scopus Publications
25815Google Scholar Citations
81Google Scholar h-index
413Google Scholar i10-index

Research Interests

Controlled drug delivery Polymeric drug delivery Targeted drug delivery Microparticles Nanoparticles Nanomedicine Anticancer

Biography

Rassoul Dinarvand, received his Pharm.D. from University of Tehran in 1988. He then successfully completed his M.Sc. in 1990 and his Ph.D. in 1993 in the field of Controlled Drug Delivery Systems at the University of Manchester, UK. He then joined Faculty of Pharmacy, Tehran University of Medical Sciences in 1994 as a faculty member. He was promoted to full professorship in Pharmaceutics in 2005. He then became the Dean of the Faculty of Pharmacy at Tehran University of Medical Sciences in 2009 for 4 years. Prof. Dinarvand has been active in the pharmaceutical administration in both industry and government at the highest level: seven years as CEO of several Pharmaceutical companies and twice as Deputy Minister of Health and Head of Iran Food and Drug Administration (8 years). He has also been involved in pharmacoeconomy and national drug policy research. However his main research interest is in the area of polymeric drug delivery systems and has published over 350 international papers

Education

Pharm. D. from Tehran university 1982-1988 M.Sc. from Manchester University 1989-1990 Ph.D. from Manchester University 1991-1994

Recent Scopus Publications

  1. Localized co-delivery of in-situ hydrogel containing ibrutinib-PLGA-PEG-folate nanoparticle and octreotide microsphere to glioblastoma
    Drug Delivery and Translational Research, 2026
  2. PLGA-integrated micro/nanoparticles for cargo delivery and nanomedicine of lung cancer
    International Journal of Pharmaceutics, 2026
  3. Citrus limon-Derived Extracellular Vesicles Promote Hair Growth
    Applied Biochemistry and Biotechnology, 2026
  4. Redox responsive functionalised mesoporous silica nanoparticle for targeted drug delivery of doxorubicin
    Journal of Drug Targeting, 2026
  5. Oral delivery of liraglutide using CPP/hyaluronic acid-modified mesoporous silica nanoparticles: A virus-inspired strategy for intestinal absorption
    Biomaterials Advances, 2026

Links